Wolters Kluwer Debuts New Facts & Comparisons eAnswers with Crystal Clear Interface and Boosted Content

Tuesday, November 15, 2016

November 15, 2016 – The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, has re-launched its Facts & Comparisons® eAnswers online drug reference solution with a newly redesigned user interface, new tools, and boosted content. These enhancements, inspired by customer feedback, help create a faster, cleaner resource for better drug intelligence.

One of the industry-leading applications from Wolters Kluwer Clinical Drug Information, Facts & Comparisons has been a trusted medication safety resource in the pharmacy community for over 70 years. The re-designed Facts & Comparisons eAnswers has incorporated customer suggestions to create a more intuitive online user interface aimed at improving workflow for more efficient business practices and enhanced patient care.

All current subscribers will be automatically upgraded to the new Facts & Comparisons eAnswers and eligible for additional enhancements, including:

  • New Crystal Clear Interface
    • Common sense navigation including top tool bar, smart field navigation tree, and “jump to” capabilities
    • Improved searching and workflow with less on-screen clutter
  • New Tools and Boosted Content
    • Product Availability Tool to help you quickly check drug product availability, find generic alternatives, and look up AB ratings and NDCs
    • Expanded patient education leaflets, available in up to 19 languages (optional add-on module)
    • Added and expanded monograph content, including medication safety issues and drug shortage information

"The retail pharmacy industry, healthcare commerce, and hospitals have long trusted Facts & Comparisons to connect professionals to vital drug information and medication safety data. But now, we’ve made it even easier for them to access it,” said Denise Basow, MD, President & CEO of Clinical Effectiveness at Wolters Kluwer. “The new interface is so clean and intuitive, professionals will be impressed with how efficiently they find the information they seek, and that will pay dividends in time saved, care enhanced, claims processed, and patients protected."

Watch this video to preview the new interface and learn more about enhanced content and tools.

About Wolters Kluwer

Wolters Kluwer N.V. (AEX:WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.


Wolters Kluwer | Clinical Effectiveness
Meagan McCord, 330-650-6506
Manager, Marketing Communications, Clinical Drug Information